Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu
HB23-1130

Drug Coverage For Serious Mental Illness

Concerning requirements for prescription drug coverage for serious mental illness, and, in connection therewith, making an appropriation.
Session:
2023 Regular Session
Subject:
Health Care & Health Insurance
Bill Summary

Effective January 1, 2025, section 1 of the bill, with respect to step-therapy protocols (protocols) for health insurance, the bill defines "serious mental illness" and prohibits the protocols from requiring a person to try more than one prescription drug prior to receiving coverage for the drug recommended by the person's health-care provider. If certain conditions are met and attested to by the person's health-care provider, the carrier, private utilization review organization, or pharmacy benefit manager must cover the drug recommended by the person's health-care provider.

The bill defines "serious mental illness" for purposes of the "Colorado Medical Assistance Act" in the same manner as the term is defined for commercial health insurance. The bill requires the medical services board to require a review for coverage of a new drug approved by the federal food and drug administration for a serious mental illness within 90 days after the drug is approved.

The bill appropriates $53,117 to the department of health care policy and financing from the general fund for use by the executive director's office to implement the bill, and recognizes that the department anticipates receiving an equal amount of federal funds to implement the bill.

(Note: Italicized words indicate new material added to the original summary; dashes through words indicate deletions from the original summary.)


(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

Status

Introduced
Passed

Menu

Bill Text

Email addresses for the Colorado legislature have changed from the @state.co.us domain to the @coleg.gov domain on December 1, 2022. Details